STELLARIS PHARMACEUTICALS ApS: Financial statements 2017
CVR: 34708215
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
STELLARIS PHARMACEUTICALS ApS (CVR 34708215) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -45,200 and a net result of DKK -78,398 compared with DKK -117,646 the year before. Equity in the 2017 report amounted to DKK -106,526.
- Gross Profit
- DKK -45,200
- Profit/Loss
- DKK -78,398
- Equity
- DKK -106,526
- Total Assets
- DKK 28,495
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -45 t. | -78 t. | -107 t. | 0 |
| 2016 | - | - | -118 t. | -575 t. | - |
| 2015 | - | - | -127 t. | -457 t. | - |
| 2014 | - | - | -384 t. | -330 t. | - |
Official annual report
Keep an eye on STELLARIS PHARMACEUTICALS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2016. The net result was DKK -117,646.
About STELLARIS PHARMACEUTICALS ApS
STELLARIS PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Birgit Ter-Borch Gram Lilienfeldt Schjoldager. The company is owned by Ranoda Holding ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -475,262 and a net result of DKK -594,882 compared with DKK -486,941 the year before. Equity in the 2025 report amounted to DKK -3,565,816.